PR Newswire - Financial

QMed, Inc. Add to My Watchlist

(OTCPK: QMED)

Detailed Quote

News

Last Price	0.01 (11.20.09 5:20 PM EST)
Change (%)	-0.00 (-15.83%)
Volume	61,362
Open	0.01
Previous Close	0.01
Day High	0.01
Day Low	0.01
Bid	N/A
Ask	N/A

Average Volume	21,848
Shares Outstanding	17.08M
Market Cap	172.5K
Year High	0.04
Year Low	0.00
Earnings Per Share	N/A
P/E Ratio	N/A
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)
SOSR	0.01	+0.00 (+0.00)
BBAL	0.01	+0.00 (+0.00)
AKESQ	0.01	+0.00 (+0.00)
SWVL	0.00	+0.00 (+0.00)
NAWL	0.00	+0.00 (+0.00)
NAWL	0.00	+0.00 (+100.00%)
ABDS	0.01	+0.00 (+15.85%)

Thu, May 15, 2008
	QMed, Inc. Announces it Will Discontinue its Operations - PR Newswire
Fri, Apr 18, 2008
	QMed, Inc. Reports First Quarter Results - PR Newswire
	QMed, Inc. Receives NASDAQ Delisting Letter - PR Newswire
Mon, Apr 07, 2008
	QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS - PR Newswire
Wed, Mar 26, 2008
	QMed, Inc. Reports Year-End and Fourth Quarter Results - PR Newswire
More Featured Content

Sat, Jan 10, 2009
	The Week in Review: January Off to a Slow Start The aftereffects of the holiday season made themselves felt this past week in a greatly constricted news flow from the China biopharma. Although the stories were smaller in number, some of them were, nevertheless, truly significant. Chief among these was the announcement that Singapore biotech S*BIO optioned its two leading drug candidates to Onyx Pharmaceuticals for up to $550 million; Forma Therapeutics, with a lab in Beijing, closed a $25 million venture round; e-Therapeutics opened an office in Nanjing to offer its computational drug discovery platform; and Q-Med AB obtained registration approval in China for Restylane®, its dermal filler. More details... Stock Symbols: (NSDQ: ONXX) (AIM: ETX) (STO: QMED) - ChinaBio Today
Wed, Jan 07, 2009
	Q-Med Granted China Registration for Dermal Filler Q-Med AB, a biotech/medical device company based in Sweden, obtained registration approval in China for Restylane®, its dermal filler. The company will follow up with an application for sales approval, which Q-Med expects will allow launch of the product within six months. Restylane® is a hyaluronic acid injection product, the first to be approved for use in China. More details... Stock Symbol: (STO: QMED) - ChinaBio Today
Fri, Apr 18, 2008
	QMed (QMED) Receives Delisting Notification Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3557995 for the full story. - StreetInsider
Thu, Apr 17, 2008
	Nasdaq Delisting Candidates, To The Pink Sheets The list of possible delisting candidates is too long to publish here. These companies are called "non-compliant" usually for late SEC filings or stock prices which trade below the exchange minimum share price. Most of these companies can appeal and go through a process to remain listed. The entire list is published.here. Among some of the notables: Applied Digital Solutions (DIGA) Atari (ATAR) Children's Place (PLCE) Conexant (CNXT) EntreMed (ENMD) Force Protection (FRPT) infoUSA (IUSA) Mindspeed (MSPD) PixelWorks (PXLW) QMed (QMED) Sonic Foundry (SOFO) Sonic Solutions (SNIC) TranSwitch (TXCC) Zila (ZILA) Douglas A. McIntyre - 24/7 Wall St.
Fri, Nov 02, 2007
	QMed May Seek Bankruptcy Protection QMed Inc. ( Nasdaq: QMED) is considering seeking bankruptcy protection after failing to raise sufficient capital to support operations. Shares of the clinical information management system provider plunged $1.72 to 35 cents.... - Market News
More News

Wed, Jul 12, 2006
	Wall Street to Main Street: News, Views and Commentary: July 12, 2006 Seacoast Banking Corp, Nutrisystem, Monster Worldwide, Stericycle, Synergx Systems, Leading Brands, Valentis, Inc - NAMC Radio
Mon, Jul 10, 2006
	Wall Street to Main Street: News, Views and Commentary: July 10, 2006 McDonalds, Google, Walt Disney Co, RadioShack, Tom Online, LESCO, LaBranche Co - NAMC Radio
More Podcasts

10/08/07		877-356-9649
08/20/07		Special Conference QMed, Inc. to Present at Noble Financial Services Small Cap Conference Archive for QMED
07/09/07		Q2 2007 Earnings Archive for QMED
05/30/07		Special Conference Archive for QMED

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs